Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair

Currently available data describing the gene expression and regulation, secretion, distribution, and protein chemistry of osteopontin (OPN) all are consistent with the notions of this protein functioning as an inhibitor of mineralization and/or as a mediator of cell‐matrix and matrix‐matrix/mineral adhesion (cohesion) during the formation, turnover, and repair of normal and pathological mineralized tissues. The properties and overall integrity of mineralized tissues are in part dictated by the nature of their interfaces—sites where organic and inorganic components of the extracellular matrix interact to provide biomechanical strength, regulate mineral ion homeostasis, and influence cellular events involved in mineralized tissue modeling, remodeling, and repair. High‐resolution, colloidal‐gold immunocytochemistry has been used to characterize the proteinaceous composition of these interfaces and to establish that the phosphorylated sialoprotein, OPN, is a major component found at these sites where it accumulates as a dense, planar “coating” of organic material termed either a cement line or a lamina limitans. Structural/functional features of OPN predict an ability of this protein to regulate calcification in the matrix proper of mineralized tissues and to participate, more specifically, in cell‐matrix and matrix‐matrix/mineral adhesion in laminae limitantes and cement lines, respectively. From the ultrastructural immunocytochemical data presented herein for OPN illustrating the cellular expression and extracellular matrix distribution of this protein, it is demonstrated that the production of OPN is one of the earliest, and latest, secretory activities of the osteoblast lineage and that this activity manifests itself morphologically as a cement line or a lamina limitans, respectively, at bone matrix interfaces. In laminae limitantes at bone surfaces, OPN appears to be involved in osteoclast adhesion and possibly haptotaxis. An OPN‐containing cement line is also present at hard tissue interfaces in rat tooth, against osseointegrated titanium and hydroxyapatite implants and at the margins of surgically created bone defects—and there may influence biological adhesion in a manner similar to that proposed for normal bone. It is suggested, therefore, that in addition to its potential for influencing cell adhesion/dynamics in bones and teeth, OPN in cement lines may act as an interfacial adhesion promotor between apposing substrates, therein maintaining the overall integrity of bone during the bone remodeling sequence and “bonding” dissimilar tissues (or biocompatible materials) together in biological composites such as teeth and osseointegrated implants. © 1996 Wiley‐Liss, Inc.

[1]  D B Burr,et al.  Composition of the cement line and its possible mechanical role as a local interface in human compact bone. , 1988, Journal of biomechanics.

[2]  T. Yoneda CYTOKINES IN BONE: Local Translators in Cell-To-Cell Communications , 1993 .

[3]  M. Glimcher,et al.  Expression and ultrastructural immunolocalization of a major 66 kDa phosphoprotein synthesized by chicken osteoblasts during mineralization in vitro , 1990, The Anatomical record.

[4]  M. McKee,et al.  Osteopontin and the Bone Remodeling Sequence , 1995, Annals of the New York Academy of Sciences.

[5]  M. Glimcher,et al.  Effects of fixation and demineralization on the retention of bone phosphoprotein and other matrix components as evaluated by biochemical analyses and quantitative immunocytochemistry , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Frasca Scanning-electron microscopy studies of 'ground substance' in the cement lines, resting lines, hypercalcified rings and reversal lines of human cortical bone. , 1981, Acta anatomica.

[7]  F. Reinholt,et al.  Osteopontin--a possible anchor of osteoclasts to bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Robey The Biochemistry of Bone , 1989 .

[9]  D. Burr,et al.  Morphology of the osteonal cement line in human bone , 1987, The Anatomical record.

[10]  M. McKee,et al.  Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and α2HS‐glycoprotein) proteins in rat bone , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  F. Reinholt,et al.  Ultrastructural immunolocalization of osteopontin in metaphyseal and cortical bone. , 1991, Matrix.

[12]  M. McKee,et al.  Bone acidic glycoprotein‐75 self‐associates to form macromolecular complexes in vitro and in vivo with the potential to sequester phosphate ions , 1997, Journal of cellular biochemistry.

[13]  P. Bianco Ultrastructural immunohistochemistry of noncollagenous proteins in calcified tissues , 1990 .

[14]  L. Water,et al.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. , 1994, Molecular biology of the cell.

[15]  M. Bolander,et al.  Genetic expression of extracellular matrix proteins correlates with histologic changes during fracture repair , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Y. Kitamura,et al.  Structure and expression of the mRNA encoding urinary stone protein (osteopontin). , 1993, The Journal of biological chemistry.

[17]  M. McKee,et al.  Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  B. Philipson COMPOSITION OF CEMENT LINES IN BONE , 1965, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  A. Chambers,et al.  Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. , 1993, Cancer research.

[20]  S. Weiner Organization of Organic Matrix Components in Mineralized Tissues , 1984 .

[21]  J. P. Scherft The lamina limitans of the organic matrix of calcified cartilage and bone. , 1972, Journal of ultrastructure research.

[22]  A. Mukherjee,et al.  Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. , 1994, Journal of biochemistry.

[23]  K. Donath,et al.  Enzyme, lectin and immunohistochemistry of plastic embedded undecalcified bone and other hard tissues for light microscopic investigations. , 1991, Biotechnic & Histochemistry.

[24]  M. McKee,et al.  In vivo experimentation on rat incisor enamel organs through a surgical window , 1984, The Anatomical record.

[25]  A. Poole,et al.  Localisation of plasma α2HS glycoprotein in mineralising human bone , 1975, Nature.

[26]  J. Lian,et al.  Induction of bone‐related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro , 1993, Journal of cellular biochemistry.

[27]  A. Mukherjee,et al.  Calcium-binding properties of osteopontin derived from non-osteogenic sources. , 1993, Journal of biochemistry.

[28]  A. Boskey Noncollagenous matrix proteins and their role in mineralization. , 1989, Bone and mineral.

[29]  S. Weiner,et al.  Organization of extracellularly mineralized tissues: a comparative study of biological crystal growth. , 1986, CRC critical reviews in biochemistry.

[30]  A. Nanci,et al.  Routine use of backscattered electron imaging to visualize cytochemical and autoradiographic reactions in semi-thin plastic sections. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  M. Glimcher,et al.  Comparison of two phosphoproteins in chicken bone and their similarities to the mammalian bone proteins, osteopontin and bone sialoprotein II. , 1990, Biochemical and biophysical research communications.

[32]  S. Hwang,et al.  Structural aspects of the reversal phase of alveolar bone remodelling. , 1994, Journal of anatomy.

[33]  C. W. Prince,et al.  Osteopontin, a substrate for transglutaminase and factor XIII activity. , 1991, Biochemical and biophysical research communications.

[34]  M. Helder,et al.  Dissimilar expression patterns for the extracellular matrix proteins osteopontin (OPN) and collagen type I in dental tissues and alveolar bone of the neonatal rat. , 1993, Matrix.

[35]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[36]  K. Ohya,et al.  Osteopontin mRNA expression during bone resorption: an in situ hybridization study of induced ectopic bone in the rat. , 1993, Bone and mineral.

[37]  D B Burr,et al.  Errors in bone remodeling: toward a unified theory of metabolic bone disease. , 1989, The American journal of anatomy.

[38]  L. Suva,et al.  Pattern of gene expression following rat tibial marrow ablation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  M. Horton,et al.  Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. , 1991, Experimental cell research.

[40]  A. Bronckers,et al.  Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  J. Aubin,et al.  OSTEOBLASTIC CELL LINEAGE , 1993 .

[42]  M. McKee,et al.  Postembedding colloidal‐gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues , 1995, Microscopy research and technique.

[43]  G. Hunter,et al.  Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. , 1994, The Biochemical journal.

[44]  M. Tavassoli,et al.  The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue , 1969, The Anatomical record.

[45]  M. Glimcher,et al.  Developmental appearance and ultrastructural immunolocalization of a major 66 kDa phosphoprotein in embryonic and post‐natal chicken bone , 1990, The Anatomical record.

[46]  B. Clarke,et al.  Distribution of noncollagenous proteins in the matrix of adult human bone: Evidence of anatomic and functional heterogeneity , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  S. Nomura,et al.  In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[48]  M. Young,et al.  MOLECULAR AND CELLULAR BIOLOGY OF THE MAJOR NONCOLLAGENOUS PROTEINS IN BONE , 1993 .

[49]  M. C. Farach-Carson,et al.  Evidence for the formation of a complex between osteopontin and osteocalcin , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  P. Nijweide,et al.  Identification of osteopontin in isolated rabbit osteoclasts. , 1992, Biochemical and biophysical research communications.

[51]  E. Neilson,et al.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  F. Reinholt,et al.  Macromolecules in bone matrix. , 1989, Connective tissue research.

[53]  H. Dvorak,et al.  Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a , 1992, Annals of the New York Academy of Sciences.

[54]  M. Young,et al.  Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. , 1992, Clinical orthopaedics and related research.

[55]  M. Bendayan 3 – Protein A–Gold and Protein G–Gold Postembedding Immunoelectron Microscopy , 1989 .

[56]  H. Frost Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's Law: The remodeling problem , 1990, The Anatomical record.

[57]  M. Glimcher,et al.  High‐resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia , 1992, The Anatomical record.

[58]  T. Hefferan,et al.  Structure and molecular regulation of bone matrix proteins , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  M. Somerman,et al.  Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. , 1989, Matrix.

[60]  D. Heinegård,et al.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. P. Scherft The lamina limitans of the organic bone matrix: formation in vitro. , 1978, Journal of ultrastructure research.

[62]  G. Mundy Cytokines and growth factors in the regulation of bone remodeling , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  W. Butler,et al.  The nature and significance of osteopontin. , 1989, Connective tissue research.

[64]  R. Dodds,et al.  Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. , 1993, Journal of cell science.

[65]  H. Warshawsky,et al.  A TECHNIQUE FOR THE FIXATION AND DECALCIFICATION OF RAT INCISORS FOR ELECTRON MICROSCOPY , 1967, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[66]  Subburaman Mohan,et al.  Growth factors to stimulate bone formation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  W. Butler,et al.  A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone γ‐carboxyglutamic acid (Gla)‐containing protein in osteoblasts , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  Y. Kuboki,et al.  Differences in Composition of Cell-attachment Sialoproteins between Dentin and Bone , 1993, Journal of dental research.

[69]  D. Burr,et al.  A hypothetical mechanism for the stimulation of osteonal remodelling by fatigue damage. , 1982, Journal of biomechanics.

[70]  E. Manseau,et al.  Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. , 1992, Molecular biology of the cell.

[71]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[72]  Patt Hm,et al.  Bone marrow regeneration after local injury: a review. , 1975 .

[73]  M C Farach-Carson,et al.  Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. , 1993, The Journal of biological chemistry.

[74]  A. Boskey,et al.  Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. , 1993, Bone and mineral.

[75]  D. Denhardt,et al.  Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.